Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation KIF13A_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-25207 | KIF13A | up-regulates | SATB1 | represses | R-1681 | 24 | 1 | Drugs (23) Regulator Drugs (0)Regulon Drugs (23)TRELAGLIPTIN SUCCINATE, TD-139, VILDAGLIPTIN, DAVANAT, ALOGLIPTIN BENZOATE, SAXAGLIPTIN, ANAGLIPTIN, TENELIGLIPTIN, CARMEGLIPTIN, BEGELOMAB, OMARIGLIPTIN, SAXAGLIPTIN HYDROCHLORIDE, GEMIGLIPTIN, BISEGLIPTIN, SITAGLIPTIN, DUTOGLIPTIN, EVOGLIPTIN, ALOGLIPTIN, BELAPECTIN, LINAGLIPTIN, TRELAGLIPTIN, GOSOGLIPTIN, SITAGLIPTIN PHOSPHATE |
CMF-25212 | KIF13A | down-regulates | FOSL1 | activates | R-1992 | 12 | 1 | Drugs (3) |
CMF-25213 | KIF13A | down-regulates | SMAD3 | activates | R-2549 | 15 | 1 | Drugs (3) |
CMF-25214 | KIF13A | down-regulates | TFCP2L1 | activates | R-2535 | 3 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-25215 | KIF13A | up-regulates | PBX1 | represses | R-3166 | 12 | 2 | Drugs (4) |